When analyzing uptake characteristics by the histological subtype, there was no significant change in the PSMA uptake seen for lymph node metastases of ccRCC (median SUVmax 7.9 vs. 12.5; p = 0.48; median SUVmean 6.1 vs. 7.6; p = 0.66) or pRCC (median SUVmax 6.1 vs. 6.0; p > 0.99; median SUVmean 3.7 vs. 3.9; p > 0.99). The gene discussed is FOLH1; the disease is metastatic malignant neoplasm in the lymph nodes.